In this study we identified patient characteristics linked to adverse renal function outcomes after partial nephrectomy. We performed a retrospective study of 387 patients between 2006 and 2014 who underwent a partial nephrectomy at Memorial Sloan Kettering Cancer Center. In univariable analysis, we determined that advanced age at surgery, large tumor size, male sex, longer ischemia time, smoking and hypertension were linked to lower postoperative GFR. In multivariable analysis, advanced age, lower preoperative GFR and longer ischemia time were independent predictors of postoperative decline in renal function. Background: The purpose of the study was to identify patient and disease characteristics that have an adverse effect on renal function after partial nephrectomy. Patients and Methods: We conducted a retrospective review of 387 patients who underwent partial nephrectomy for renal tumors between 2006 and 2014. A line plot with a locally weighted scatterplot smoothing was generated to visually assess renal function over time. Univariable and multivariable longitudinal regression analyses incorporated a random intercept and slope to evaluate the association between patient and disease characteristics with renal function after surgery. Results: Median age was 60 years and most patients were male (255 patients [65.9%]) and white (343 patients [88.6%]). In univariable analysis, advanced age at surgery, larger tumor size, male sex, longer ischemia time, history of smoking, and hypertension were significantly associated with lower preoperative estimated glomerular filtration rate (eGFR). In multivariable analysis, independent predictors of reduced renal function after surgery included advanced age, lower preoperative eGFR, and longer ischemia time. Length of time from surgery was strongly associated with improvement in renal function among all patients. Conclusion: Independent predictors of postoperative decline in renal function include advanced age, lower preoperative eGFR, and longer ischemia time. A substantial number of subjects had recovery in renal function over time after surgery, which continued past the 12-month mark. These findings suggest that patients who undergo partial nephrectomy can experience long-term improvement in renal function. This improvement is most pronounced among younger patients with higher preoperative eGFR.
Introduction
Renal cell carcinoma (RCC) has an annual estimated incidence of 64,000 cases in the United States.
1 Five-year relative survival rates have increased from 50% in 1975 to 1977 to 73% in 2003, largely because of the increasing use of abdominal imaging for unrelated indications, leading to a stage migration toward diagnosis of smaller, lower stage tumors. 2, 3 Historically, radical nephrectomy (RN) has been the standard of care for renal masses. However, a growing body of evidence has indicated that after radical kidney surgery, patients are more likely to be diagnosed with chronic kidney disease (CKD) or end-stage renal disease-medical conditions that are associated with increased cardiovascular morbidity and risk of noncancerrelated death. 4, 5 Optimizing perioperative renal function has 1 therefore become a key secondary goal in the surgical management of kidney tumors. Nephron-sparing surgery for renal cortical tumors has been shown to have superior renal functional outcomes while providing equivalent oncologic outcomes in appropriately selected patients. 6 Putative baseline clinical demographic factors that affect postoperative renal function in patients who undergo extirpative renal surgery include preoperative estimated glomerular filtration rate (eGFR), age at surgery, tumor size, and the presence of medical comorbidities such as diabetes and hypertension. 7, 8 In a comparison between patients who underwent donor nephrectomy (DN) versus RN for a renal cortical tumor, at a mean follow-up of 15 months postsurgery, RN patients were more likely to have low eGFR, proteinuria, and de novo elevated creatinine levels than those who underwent DN. 9 These findings support the notion that nonsurgical factors as well as vulnerabilities affecting cancer patients play a role in subsequent renal function. Other lifestyle factors such as smoking might also have an effect on renal function, with some studies suggesting that current or former smokers are susceptible to CKD. 10 The aim of this study was to investigate the natural history of renal function after surgery and to identify independent predictors of reduced postoperative renal function.
Patients and Methods
After institutional review board approval was obtained, data on 513 patients who underwent either partial nephrectomy (PN) or RN for kidney neoplasms at Memorial Sloan Kettering Cancer Center between 2006 and 2014 were collected from a kidney cancer surgical database for a single surgeon (J.A.C.) who obtains extensive perioperative medical data on each patient. All surgeries were performed with a minimally invasive approach and thus the tumor excision was completed under warm ischemia in the shortest amount of time possible to safely remove the tumor and repair the renal parenchymal defect. Patients were excluded for having 2 separate surgeries within 1 year (n ¼ 11), transitional cell carcinoma (n ¼ 3), receipt of chemotherapy (n ¼ 52), or not having any postoperative eGFR measurements (n ¼ 8). Because the number of patients receiving RN in this data set was small (n ¼ 52), analysis was limited to patients who received PN. The final sample size for analysis was 387 patients with a total of 4026 eGFR measurements.
Serum creatinine (SCr) values were collected at the preoperative visit and at all postoperative visits. Patients were seen for follow-up visits in the clinic every 3 to 6 months postoperatively, on average. We used SCr to calculate eGFR values using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) formula 11 as fol-
SCr is in milligrams per deciliter, k is 0.7 for women and 0.9 for men, a is À0.329 for women and À0.411 for men, minimum indicates the minimum of SCr/k or 1, and maximum indicates the maximum of SCr/k or 1. If patients had more than 1 measurement on the same date, the multiple measurements were averaged for analysis.
To explore trends in the data, we plotted the trajectory of each patient's eGFR from their immediate postoperative visit up to 5 years postoperatively, and used a locally weighted scatterplot smoothing to look at trends in the data overall. We analyzed the association between patient and disease characteristics with preoperative eGFR using the Wilcoxon rank sum test when continuous and Fisher exact test when categorical. The primary end point was postoperative eGFR over time. We fit linear mixed models to the data, incorporating a random intercept and random slope for each patient. Each model included a fixed effect for the factor of interest as well as a fixed effect for time. This model accounts for the correlation between multiple observations of eGFR within a patient, and allows each patient in the data to have an individual intercept and slope. A multivariable model incorporated factors selected on the basis of a combination of clinical and statistical considerations.
A P value < .05 was considered statistically significant. All analyses were conducted using R version 3.1.0 (R Core Development Team, Vienna, Austria) including the "nlme" package.
Results
Of the 387 patients included in our analysis, 64 (16.5%) had eGFR ! 90, 213 (55.0%) had eGFR 60 to 89, and 110 (28.4%) had eGFR < 60 preoperatively. Patient and disease characteristics according to preoperative eGFR are presented in Table 1 . Median age was 60.1 (range, 23.0-85.3) and most patients were male (255 patients [65.9%]) and white (343 patients [88.6%]). There were differences in age (P < .001), sex (P ¼ .001), smoking status (P ¼ .005), hypertension (P < .001), preoperative diastolic blood pressure (DBP; P ¼ .007), tumor size (P < .001), and ischemia time (P < .001) according to preoperative eGFR.
Longitudinal postoperative eGFR trajectories for each patient are plotted in Figure 1 . Median follow-up time was 24 months (range, 0-68). Included patients had a median of 9 eGFR measurements during follow-up (range, 2-76). On average, patients experienced an initial decline in eGFR after surgery, followed by a slight increase and stabilization. To further investigate the trend in postoperative eGFR over time, we fit a linear mixed model that included a fixed effect for time and a random intercept and slope for each patient and found that each 1-month increase in time was significantly associated with a 0.11 (95% confidence interval, 0.07-0.15) unit increase in eGFR (P < .001), indicating that there is a significantly increasing trend in postoperative eGFR over time.
In univariable analysis (Table 2) , older age (P < .001), male versus female sex (P ¼ .040), ever smoker status (P ¼ .001), higher American Society of Anesthesiologists stage (P < .001), hypertension (P < .001), higher preoperative systolic blood pressure (P ¼ .003), larger tumor size (P ¼ .002), and longer ischemia time (P < .001) were associated with decreased postoperative eGFR over time. Only higher preoperative eGFR (P < .001) was associated with increased postoperative eGFR over time. Forty patients were missing data on ischemia time, so multivariable analysis is among 347 patients with complete data. In multivariable analysis incorporating age, smoking status, hypertension, tumor size, ischemia time, preoperative eGFR, and months from surgery as fixed effects (Table 3) , only older age (P < .001) and longer ischemia time (P ¼ .015) remained significantly independently associated with decreased postoperative eGFR over time. Higher preoperative eGFR (P < .001) and months from surgery (P < .001) remained significantly associated with increased postoperative eGFR over time.
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Discussion
The long-term effects of extirpative renal surgery on postoperative kidney function along with the extent to which preexisting clinical factors affect this recovery, remain poorly understood. In the present analysis of 387 patients who underwent PN at a referral cancer center, we found that increases in postoperative renal function occurred in a substantial number of patients, which continued past the 12-month postsurgical mark. This increase was most pronounced in younger patients with higher preoperative eGFR. Although baseline medical characteristics such as advanced age, larger tumor size, male sex, history of smoking, hypertension, and longer ischemia time were significantly associated with lower preoperative eGFR, only advanced age, lower preoperative eGFR, and longer ischemia time were independently predictive of decreasing renal function after surgery. These results stand in contrast to several previous studies that have reported baseline risk factors such as diabetes, sex, and T stage to be independently influential on postoperative renal function. 12, 13 Because many patients present with several of the aforementioned comorbidities, one might postulate that each individual disease might not predict postsurgical renal recovery, but rather the overall renal injury that occurs as a result of these diseases and surgical variables are the critical factors. This combined effect might be reflected in a lower preoperative eGFR, which, in conjunction with age and longer ischemia time, are ultimately among the most important clinical variables to consider when counseling patients. The present study revealed that after an initial decline, renal function appears to stabilize and gradually increase over ensuing months postoperatively on average. Intriguingly, improvements in renal function continued past the 12-month period, which was also shown in a similar report by Chung et al, who showed improvements in renal function up to 5 years postoperatively. 7 Furthermore, a recent analysis from our institution 14 in which a unique subset of RN patients were evaluated, showed that overall, 49% of patients experienced a recovery to baseline eGFR after an initial postoperative decrease, and this renal recovery was significantly more . The previous study, however, strictly evaluated RN patients. The current investigation illustrates that renal recovery occurs in PN patients as well, continues past the first postoperative year, and is affected by baseline comorbidities and surgical ischemia time.
Interrupting the flow of blood to the kidney is often necessary during PN, particularly because it allows the surgeon to work in a relatively bloodless field, thus providing the ability to safely remove the entire tumor and repair the renal parenchymal defect. An untoward consequence of clamping the arterial blood supply to the kidney is the potential loss of otherwise healthy nephrons. Although previous studies have shown that renal parenchymal tissue is quite tolerant to ischemia, 15 it is clear that longer ischemia time during PN is associated with renal functional decline. 16 The degree and timing of renal functional recovery is currently unclear, however, it has been previously shown that renal function decreases immediately after PN and often partially recovers to a new baseline between 3 weeks to 3 months postoperatively. 17 In contrast, our results suggest that this functional recovery might persist past the 12-month mark. Furthermore, a recent collaborative review of the literature on ischemia time suggests, similar to our findings, that renal functional recovery after PN is closely associated with the preoperative eGFR as well as the amount of healthy kidney preserved. 18 Thus, limiting the ischemia time and maximizing healthy renal tissue represents important modifiable surgical factors that should be considered to optimize postoperative renal functional recovery. A growing body of evidence suggests that reductions in glomerular filtration rate (GFR) caused specifically by surgery (CKD-S) might be a separate entity that affects long-term renal function and survival differently than that caused by medical comorbidities (CKD-M) alone. In the present study, we found that surgical patients with extensive preexisting hypertension in univariate analysis and a lower starting eGFR in multivariable analysis were more likely to experience decreases in renal function over time compared with younger, healthier counterparts who enjoyed improvements in renal function postoperatively. A report by Lane et al 19 showed a median decline in renal function of 4.7% annually for patients with CKD-M compared with 0.7% for those with CKD-S. Postoperative GFR was not associated with reduced survival for patients with normal preoperative renal function, suggesting that the clinical effect of CKD-S might be less pronounced than that of CKD-M. Potential reasons for this difference are that because of the chronic nature of CKD-M, these patients likely have decreased renal reserve, which in turn increases the diseased nephron's susceptibility to surgical injury followed by persistent damage after surgery imparted by preexisting medical conditions such as hypertension and diabetes. Furthermore, several reports comparing renal functional outcomes between patients undergoing DN and renal surgery for RCC showed that the DN group experience significant improvements in eGFR postoperatively compared with the RCC group. 9, 20 Compared with DN patients, those with RCC are more likely to present with baseline CKD risk factors such as diabetes, hypertension, and increased age. In fact, large series have shown that up to one-third of patients with RCC present with some degree of CKD preoperatively. [21] [22] [23] This 
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suggests that postnephrectomy renal function is a complex and multifactorial process that is largely predicated on baseline renal function and the amount of preserved healthy renal tissue. Although some debate persists within the medical community regarding the clinical effect of CKD-M compared with that of CKD-S, our study shows that the simultaneous presence of both has a cumulative effect on overall kidney function after surgery. Previous studies have evaluated the relationship between smoking and RCC oncologic outcomes. 24, 25 However, few reports have explored the effect of tobacco use on renal functional recovery after surgery for renal tumors. The rate of smoking in our study was consistent with previous reports at 55% for former and current smokers. 25 We found that tobacco use measured at baseline was significantly associated with reduced preoperative eGFR, but was not an independent risk factor for compromised renal function postoperatively. One might postulate that if smoking use in this cohort was followed over time it might have been significantly associated with decreased postoperative renal function. Similarly, Heldt et al reported that tobacco use by kidney donors was associated with decreased post-transplantation renal function, further underscoring the nephrotoxic properties of cigarette smoking. 26 These results reaffirm the notion that factors that alter baseline renal function, including cigarette smoking, will subsequently affect the ability of the kidney to recover after surgical insult but might not serve as independent risk factors. Several important limitations to this study are worth noting. Primarily, the retrospective nature of this investigation leaves unmeasured confounders difficult to address. Our study design, with a lack of control group for comparison, does not address some important unmeasured variables (renal anatomy, case complexity, referral bias, etc), because there is selection bias in a single center/ single surgeon cohort, which cannot be accounted for in this study. Additionally, clinical variables change throughout the course of time, therefore, the use of a single time point to define the presence or absence of a medical ailment can under-represent the true prevalence within the study population.
Conclusion
Ultimately, we found that on average subjects experienced an increase in renal function after kidney surgery, which continued past 12 months. Independent predictors of reduced renal function after surgery included advanced age, lower preoperative eGFR, and longer ischemia time. These findings suggest that patients who undergo PN can experience long-term improvement in renal function, in particular younger patients with higher preoperative eGFR.
Clinical Practice Points
Importantly, we found that a substantial number of subjects experienced an increase in renal function after kidney surgery, which continued past 12 months. Independent predictors of reduced renal function after surgery included advanced age, lower preoperative eGFR, and longer ischemia time. These findings suggest that patients who undergo PN can experience long-term improvement in renal function, in particular younger patients with higher preoperative eGFR and shorter renal artery clamp time. We believe that our results have significant clinical relevance because of the importance of medical optimization, risk stratification, and proper patient selection in the perioperative management of renal tumors. 
